Factory Price Isopropylbenzylamine CAS NO (102-97-6) Available at good price

1. Introduction to Isopropylbenzylamine (102-97-6)

Isopropylbenzylamine is an organic compound with the chemical formula C10H15N. It is a structural isomer of methamphetamine and belongs to the class of substituted phenethylamines. Isopropylbenzylamine has garnered attention due to its potential misuse as a cutting agent or adulterant in illicit drug preparations, particularly methamphetamine. Understanding its properties and implications is crucial for regulatory enforcement and public health efforts.

2. Chemical Structure and Composition

Isopropylbenzylamine consists of a benzene ring substituted with an isopropyl group (-CH(CH3)2) and an amino group (-NH2) at different positions on the ring. This structural arrangement gives rise to its distinct chemical properties and reactivity. While structurally similar to methamphetamine, isopropylbenzylamine lacks the stimulant effects associated with the latter.

3. Physical Properties of Isopropylbenzylamine

Isopropylbenzylamine typically appears as a colorless to pale yellow crystalline solid or powder. It has a melting point ranging from 35 to 40°C and is sparingly soluble in water but soluble in organic solvents such as ethanol and acetone. These physical properties influence its handling, storage, and detection in various contexts.

4. Misuse as an Adulterant in Illicit Drugs

Isopropylbenzylamine gained notoriety for its use as a cutting agent or adulterant in illicit drug preparations, particularly methamphetamine. Its physical resemblance to methamphetamine and similar solubility properties make it an attractive additive for increasing the bulk and perceived potency of illicit drugs. However, unlike methamphetamine, isopropylbenzylamine lacks significant psychoactive effects.

5. Analytical Detection and Identification

Detection and identification of isopropylbenzylamine pose challenges due to its structural similarity to methamphetamine and other substituted phenethylamines. Analytical techniques such as gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) are employed to differentiate between isopropylbenzylamine and target compounds in forensic and toxicological analyses.

6. Health Risks and Adverse Effects

Limited toxicological data are available on isopropylbenzylamine, but its misuse as an adulterant in illicit drugs raises concerns about potential health risks and adverse effects. Ingestion or inhalation of products containing isopropylbenzylamine may lead to symptoms such as agitation, anxiety, cardiovascular effects, and neurological impairment. Further research is needed to elucidate its pharmacological profile and toxicological properties.

7. Regulatory Control and Enforcement

Regulatory agencies and law enforcement authorities monitor the distribution and use of isopropylbenzylamine to combat illicit drug manufacturing and trafficking. Efforts to control the availability and distribution of precursor chemicals, including isopropylbenzylamine, aim to disrupt illicit drug production networks and protect public health and safety.

8. Public Awareness and Prevention

Public awareness campaigns and educational initiatives play a crucial role in preventing the misuse of isopropylbenzylamine and other adulterants in illicit drugs. By informing individuals about the risks associated with drug use and the presence of adulterants, these efforts empower communities to make informed decisions and seek help when needed.

9. Collaboration and Information Sharing

Collaboration among stakeholders, including law enforcement agencies, regulatory bodies, healthcare professionals, and scientific researchers, is essential for addressing the challenges posed by isopropylbenzylamine and other emerging drug threats. Information sharing, data analysis, and coordinated efforts enhance detection capabilities, response strategies, and public health interventions.

10. Research and Development

Continued research into the pharmacology, toxicology, and analytical detection of isopropylbenzylamine is necessary to inform regulatory policies, improve detection methods, and mitigate associated risks. By advancing our understanding of this compound and its implications, researchers can contribute to effective prevention, intervention, and harm reduction strategies in the context of illicit drug use and abuse.